Mental illness and length of inpatient stay for medicaid recipients with AIDS

Health Services Research
Donald R HooverStephen Crystal

Abstract

To examine the associations between comorbid mental illness and length of hospital stays (LOS) among Medicaid beneficiaries with AIDS. DATA SOURCE AND COLLECTION/STUDY SETTING: Merged 1992-1998 Medicaid claims and AIDS surveillance data obtained from the State of New Jersey for adults with >or=1 inpatient stay after an AIDS diagnosis from 1992 to 1996. Observational study of 6,247 AIDS patients with 24,975 inpatient visits. Severe mental illness (SMI) and other less severe mental illness (OMI) diagnoses at visits were ascertained from ICD-9 Codes. About 4 percent of visits had an SMI diagnosis; 5 percent had an OMI diagnosis; 43 percent did not have a mental illness diagnosis, but were patients who had been identified as having an SMI or OMI history; and 48 percent were from patients with no identified history of mental illness. The overall mean hospital LOS was 12.7 days. After adjusting for measures of HIV disease severity and health care access in multivariate models, patients presenting with primary and secondary severe mental illness (SMI) diagnoses had approximately 32 percent and approximately 11 percent longer LOS, respectively, than did similar patients without a mental illness history (p<0.001 for each). But in these ...Continue Reading

References

Jun 1, 1978·Archives of General Psychiatry·M R Eastwood, S Stiasny
Oct 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·N TakeiR Murray
Apr 1, 1992·American Journal of Public Health·L E MarksonT R Fanning
Jan 1, 1992·Medical Care·V MorJ Piette
Oct 1, 1991·American Journal of Public Health·L SolomonJ Astemborski
Oct 1, 1994·The American Journal of Psychiatry·K K UldallW E Lafferty
Jun 1, 1996·Annals of Internal Medicine·M J Glesby, D R Hoover
Aug 1, 1996·International Journal of Epidemiology·H J Van HaastrechtR A Coutinho
Aug 1, 1997·Journal of Community Health·K A Bonuck, P S Arno
Nov 14, 1997·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·E L GollubB L Davidson
Mar 12, 1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·L SolomonN M Graham
Oct 27, 1998·General Hospital Psychiatry·K K UldallM Krone
May 20, 1999·The Annals of Pharmacotherapy·A L Tseng, M M Foisy
Jun 16, 2000·Journal of Urban Health : Bulletin of the New York Academy of Medicine·J L GouletP A Selwyn
May 22, 2001·AIDS Patient Care and STDs·K K Uldall, J P Berghuis
May 23, 2001·International Journal of STD & AIDS·A C ChengC K Fairley
Aug 16, 2001·Community Mental Health Journal·C H StoskopfS H Glover

❮ Previous
Next ❯

Citations

May 31, 2008·The Journal of Behavioral Health Services & Research·Ranjana BanerjeaLeonard M Pogach
Mar 29, 2014·Archives of Psychiatric Nursing·Brad MatherChristine Duffield
Nov 3, 2009·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Ranjana BanerjeaUsha Sambamoorthi
Jun 6, 2009·Journal of Advanced Nursing·Cindy Diamond Zolnierek
Nov 13, 2007·The American Journal of Drug and Alcohol Abuse·Ranjana BanerjeaLeonard M Pogach

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.